InvestorsHub Logo
Followers 18
Posts 2788
Boards Moderated 0
Alias Born 02/26/2018

Re: doogdilinger post# 32387

Wednesday, 03/17/2021 6:57:02 AM

Wednesday, March 17, 2021 6:57:02 AM

Post# of 65510
My fav. quote from yesterday’s PR - “"iPSC-based NK-cell and T-cell immunotherapies are at the forefront of innovation in one of science's most cutting-edge and well-funded fields. This explains why we are seeing near and above billion-dollar valuations for companies in this space that are in late preclinical/early clinical stages of development," said Famela Ramos,”

Boom time! Go $TSOI
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News